Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin

被引:42
作者
Costelloe, EO
Stacey, KJ
Antalis, TM
Hume, DA [1 ]
机构
[1] Univ Queensland, Dept Microbiol, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Dept Biochem, St Lucia, Qld 4072, Australia
[3] Univ Queensland, Ctr Cellular & Mol Biol, St Lucia, Qld 4072, Australia
[4] Queensland Inst Med Res, Herston, Qld 4006, Australia
关键词
serpin; lipopolysaccharide; septicemia; uPA; colony-stimulating factor-1; tumor necrosis factor alpha; inducible nitric oxide synthase;
D O I
10.1002/jlb.66.1.172
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We investigate the regulation of plasminogen activator inhibitor-2 (PAI-2) inn murine macrophages. PAI-2 mRNA Tvas inducible By bacterial lipopolysaccharide (LPS) in primary cells and macrophage-like cell Lines. Evidence is presented for a role for autocrine factors, including cyclooxygenase products but not the cytokines tumor necrosis factor alpha or interferon-beta (IFN-beta), PAI-2 mRNA levels generally varied inversely front those of its target, urokinase-type plasminogen activator (uPA), and the macrophage growth factor CSF-1, which induces uPA, inhibited PAI-2 expression hn cells treated subsequently with LPS. Expression of PAI-2 Tvas distinct from that of other LPS-inducible genes in terms of induction time course, LPS dose response, and sensitivity to co-stimulation with IFN-gamma, induction of PAI-2 mRNA in subclones of the cell hue RAW 264 was not uniform, reflecting heterogeneous expression in the parent line. The expression pattern of PAI-2 is discussed inn terms of a possible role in LPS-induced pathology such as septicemia.
引用
收藏
页码:172 / 182
页数:11
相关论文
共 51 条
  • [1] ALLEY EW, 1994, J ENDOTOXIN RES, V1, P235
  • [2] Amura CR, 1998, J IMMUNOL, V161, P2552
  • [3] CONTROL OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 GENE-EXPRESSION IN THE DIFFERENTIATION OF MONOCYTIC CELLS
    ANTALIS, TM
    DICKINSON, JL
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 205 (01): : 203 - 209
  • [4] The serine proteinase inhibitor (Serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon α/β priming
    Antalis, TM
    La Linn, M
    Donnan, K
    Mateo, L
    Gardner, J
    Dickinson, JL
    Buttigieg, K
    Suhrbier, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) : 1799 - 1811
  • [5] BACHMANN F, 1995, THROMB HAEMOSTASIS, V74, P172
  • [6] CLONING, NUCLEOTIDE SEQUENCING AND EXPRESSION OF CDNAS ENCODING MOUSE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    BELIN, D
    VASSALLI, JD
    COMBEPINE, C
    GODEAU, F
    NAGAMINE, Y
    REICH, E
    KOCHER, HP
    DUVOISIN, RM
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 148 (02): : 225 - 232
  • [7] IDENTIFICATION OF A COMMON NUCLEOTIDE-SEQUENCE IN THE 3'-UNTRANSLATED REGION OF MESSENGER-RNA MOLECULES SPECIFYING INFLAMMATORY MEDIATORS
    CAPUT, D
    BEUTLER, B
    HARTOG, K
    THAYER, R
    BROWNSHIMER, S
    CERAMI, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) : 1670 - 1674
  • [8] PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE
    CARMELIET, P
    SCHOONJANS, L
    KIECKENS, L
    REAM, B
    DEGEN, J
    BRONSON, R
    DEVOS, R
    VANDENOORD, JJ
    COLLEN, D
    MULLIGAN, RC
    [J]. NATURE, 1994, 368 (6470) : 419 - 424
  • [9] CHANG S, IN PRESS J LEUKOC BI
  • [10] MACROPHAGE FIBRINOLYTIC-ACTIVITY - IDENTIFICATION OF 2 PATHWAYS OF PLASMIN FORMATION BY INTACT-CELLS AND OF A PLASMINOGEN-ACTIVATOR INHIBITOR
    CHAPMAN, HA
    VAVRIN, Z
    HIBBS, JB
    [J]. CELL, 1982, 28 (03) : 653 - 662